Temporal association of elevated c-reactive protein and periodontal disease in men

Journal of Periodontology

Volumn 80, Issue 5, 2009, Pages 734-739

  Yoshii, Saori ^a,b   Tsuboi, Shinji ^a   Morita, Ichizo ^a   Takami, Yuko ^a   Adachi, Keiko ^a   Inukai, Junko ^a   Inagaki, Koji ^a   Mizuno, Kinichiro ^b   Nakagaki, Haruo ^a  

^a AICHI GAKUIN UNIVERSITY   (Japan)

^b Aichi Health Promotion Foundation   (Japan)

Author keywords

C reactive protein; Follow up studies; Periodontal diseases; Physical examination

Indexed keywords

C REACTIVE PROTEIN;

ADULT; AGE; AGED; ARTICLE; BLOOD; CHRONIC PERIODONTITIS; DIABETES MELLITUS; HUMAN; JAPAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; OBESITY; SMOKING; STATISTICAL MODEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CHRONIC PERIODONTITIS; DIABETES MELLITUS; HUMANS; JAPAN; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OBESITY; SMOKING; YOUNG ADULT;

EID: 66649112226     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2009.080537     Document Type: Article

References (47)

1. Aida J, Ando Y, Akhter R, Aoyama H, Masui M, Morita M. Reasons for permanent tooth extractions in Japan. J Epidemiol 2006;16:214-219.
2. Ishikawa I, Nakashima K, Koseki T, et al. Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis. Periodontol 2000 1997;14:79-111.
3. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.
4. Libby P, Ridker PM. Novel inflammatory markers of coronary risk: Theory versus practice. Circulation 1999; 100:1148-1150.
5. Rattazzi M, Puato M, Faggin E, Bertipaglia B, Zambon A, Pauletto P. C-reactive protein and interleukin-6 in vascular disease: Culprits or passive bystanders? J Hypertens 2003;21:1787-1803.
6. Slade GD, Offenbacher S, Beck JD, Heiss U, Pankow JS. Acute-phase inflammatory response to periodon-tal disease in the US population. J Dent Res 2000; 79:49-57.
7. Takami Y, Nakagaki H, Morita I, et al. Blood test values and Community Periodontal Index scores in medical checkup recipients. J Periodontol 2003;74: 1778-1784.
8. Saito T, Murakami M, Shimazaki Y, Oobayashi K, Matsumoto S, Koga T. Association between alveolar bone loss and elevated serum C-reactive protein in Japanese men. J Periodontol 2003;74:1741-1746.
9. Nishimura F, Taniguchi A, Iwamoto Y, et al. Porphyromonas gingivalis infection is associated with elevated C-reactive protein in nonobese Japanese type 2 diabetic subjects. Diabetes Care 2002;25: 1888.
10. Wakai K, Kawamura T, Umemura O, et al. Associations of medical status and physical fitness with periodontal disease. J Clin Periodontol 1999;26:664-672.
11. Salzberg TN, Overstreet BT, Rogers JD, Califano JV, Best AM, Schenkein HA. C-reactive protein levels in patients with aggressive periodontitis. J Periodontol 2006;77:933-939.
12. Armitage P, Berry G. Statistical Methods in Medical Research, 3rd ed. Oxford, U.K.: Blackwell Science; 1994:512.
13. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979.
14. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001;286: 327-334.
15. Hyman JJ, Reid BC. Epidemiologic risk factors for periodontal attachment loss among adults in the United States. J Clin Periodontol 2003;30:230-237.
16. Nishida N, Tanaka M, Hayashi N, et al. Determination of smoking and obesity as periodontitis risks using the classification and regression tree method. J Periodontol 2005;76:923-928.
17. Shimazaki Y, Saito T, Kiyohara Y, et al. The influence of current and former smoking on gingival bleeding: The Hisayama study. J Periodontol 2006;77:1430-1435.
18. Saito T, Shimazaki Y, Koga T, Tsuzuki M, Ohshima A. Relationship between upper body obesity and periodontitis. J Dent Res 2001;80:1631-1636.
19. Al-Zahrani MS, Bissada NF, Borawskit EA. Obesity and periodontal disease in young, middle-aged, and older adults. J Periodontol 2003;74:610-615.
20. Taylor GW. Bidirectional interrelationships between diabetes and periodontal diseases: An epidemiologic perspective. Ann Periodontol 2001;6:99-112.
21. Shlossman M, Knowler WC, Pettitt DJ, Genco RJ. Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc 1990;121:532-536.
22. Emrich LJ, Shlossman M, Genco RJ. Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol 1991;62:123-131.
23. Taylor GW, Burt BA, Becker MP, et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 1996;67(10, Suppl.)1085-1093.
24. Collin HL, Uusitupa M, Niskanen L, et al. Periodontal findings in elderly patients with non-insulin dependent diabetes mellitus. J Periodontol 1998;69:962-966.
25. Kopelman PG. Obesity as a medical problem. Nature 2000;404:635-643.
26. Kannel WB. Lipids, diabetes, and coronary heart disease: Insights from the Framingham Study. Am Heart J 1985;110:1100-1107.
27. Khader YS, Albashaireh ZS, Alomari MA. Periodontal diseases and the risk of coronary heart and cerebro-vascular diseases: A meta-analysis. J Periodontol 2004; 75:1046-1053.
28. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 1979;90:85-91.
29. Kannel WB, Neaton JD, Wentworth D, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRF1T. Multiple Risk Factor Intervention Trial. Am Heart J 1986;112:825-836.
30. Auerbach O, Carter HW, Garfinkel L, Hammond EC. Cigarette smoking and coronary artery disease. A macroscopic and microscopic study. Chest 1976;70: 697-705.
31. Friedman GD, Dales LG, Ury HK. Mortality in middle-aged smokers and nonsmokers. N Engl J Med 1979; 300:213-217.
32. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Multiple Risk Factor Intervention Trial Research Group. Arch Intern Med 1992; 152:56-64.
33. Stevens J, Cai J, Pamuk ER, Williamson DF, Thun MJ, Wood JL. The effect of age on the association between body-mass index and mortality. N Engl J Med 1998; 338:1-7.
34. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974;23:105-111.
35. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
36. Assmann U, Schulte H. The Prospective Cardiovascular Munster (PROCAM) study: Prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 1988;116:1713-1724.
37. Fujishima M, Kiyohara Y, Kato 1, et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes 1996;45(Suppl. 3):S14-S16.
38. Burchfiel CM, Reed DM, Strong JP, Sharp DS, Chyou PH, Rodriguez BL. Predictors of myocardial lesions in men with minimal coronary atherosclerosis at autopsy. The Honolulu heart program. Ann Epidemiol 1996;6:137-146.
39. Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003; 107: 499-511.
40. Amberger A, Maczek C, Jurgens U, et al. Co-expression of 1CAM-1, VCAM-1, ELAM-1 and Hsp60 in human arterial and venous endothelial cells in response to cytokines and oxidized low-density lipopro-teins. Cell Stress Chaperones 1997;2:94-103.
41. Ross R. Atherosclerosis - An inflammatory disease. N Engl J Med 1999;340:115-126.
42. Slade GD, Ghezzi EM, Heiss U, Beck JD, Riche E, Offenbacher S. Relationship between periodontal disease and C-reactive protein among adults in the Atherosclerosis Risk in Communities study. Arch Intern Med 2003;163:1172-1179.
43. Iwamoto Y, Nishimura F, Soga Y, et al. Antimicrobial periodontal treatment decreases serum C-reactive protein, tumor necrosis factor-alpha, but not adipo-nectin levels in patients with chronic periodontitis. J Periodontol 2003;74:1231-1236.
44. Yamazaki K, Honda T, Oda T, et al. Effect of periodontal treatment on the C-reactive protein and proinflammatory cytokine levels in Japanese periodontitis patients. J Periodontal Res 2005;40: 53-58.
45. D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005;84:269-273.
46. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 1999;20:345-357.
47. Tüter U, Kurtis B, Serdar M. Evaluation of gingival crevic-ular fluid and serum levels of high-sensitivity C-reactive protein in chronic periodontitis patients with or without coronary artery disease. J Periodontol 2007;78:2319-2324.